AKT1 and neoplasm: miR-21′s upregulation contributes to treatment resistance via its inhibition of tumor suppressors such as PTEN and its downstream activation of AKT/ERK signaling and HIF-1α–mediated angiogenesis, mechanisms implicated in promoting invasive and aggressive tumor behavior [40,54,56].